Quest Diagnostics Reports Strong Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases DividendSECAUCUS, N.J., January 30, 2025 — Quest Diagnostics Incorporated (NYSE: DGX) has recently announced its fi

]

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Quest Diagnostics’s 8K filing here.

Quest Diagnostics Company Profile

(Get Free Report)

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.

See Also